These results demonstrated that miR-595 overexpression could reverse ESCC cell growth, migration and invasion in vitro by upregulating SEMA4D, suggesting a miR-595/SEMA4D axis in ESCC cell malignant progression. The gene discussed is SEMA4D; the disease is esophageal squamous cell carcinoma.